Effekten af pioglitazon (45 mg monoterapi versus placebo) er blevet undersøgt i et mindre, 18- ugers klinisk forsøg hos type 2- diabetikere.
10 The effect of pioglitazone (45 mg monotherapy vs. placebo) was studied in a small 18-week trial in type 2 diabetics.